The drug ABRAXANE contains one active pharmaceutical ingredient (API):
Paclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation. This stability results in the inhibition of the normal dynamic reorganisation of the microtubule network that is essential for vital interphase and mitotic cellular functions.
Below package inserts are available for further reading:
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
This brand name is authorized in the following countries: Austria Australia Brazil Canada Cyprus Ecuador Estonia Spain Finland France Hong Kong Ireland Lithuania Netherlands New Zealand Poland Singapore United Kingdom United States South Africa
This drug has been assigned below unique identifiers within the countries it is being marketed: